Conference Details - Agenda

View all Conferences

Continuing Education Information

Physicians: Physicians' Education Resource is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

This activity is approved for AMA PRA Category 1 Credit

Physician Assistants: AAPA accepts category 1 credit from AOACCME, Prescribed credit from AAFP, and AMA Category 1 CME credit for the PRA from organizations accredited by the ACCME.

Second Annual Symposium for Nurses and Pharmacists Specializing in Oncology: Assessing and Managing Side Effects in the Era of Targeted Therapies

Dallas/Addison Marriott Quorum by the Galleria
Dallas, TX
October 24, 2009

Saturday, Oct 24, 2009

7:30 am Continental Breakfast and Registration
8:00 am Welcome, Introductions, Program Overview, and Presession Survey
Debra Barton and John G. Kuhn
8:20 am Keynote: Targeted Agents—Underlying Biology and Clinical Progress
Debu Tripathy
8:50 am Question-and-Answer Session
Prevention and Management of Class-Effect Toxicities in the Era of Targeted Agents
9:00 am Fatigue Associated With Multikinase Inhibitors and Other Agents
Debra Barton
9:30 am Cutaneous Toxicities With Anti–Epidermal Growth Factor Receptor and Multitargeted Agents
Mario E. Lacouture
10:00 am Adverse Events Associated With mTOR Inhibitors
John G. Kuhn
10:30 am Prevention and Management of Infusion Reactions
Joseph Bubalo
11:00 am Question-and-Answer Session/Panel Discussion With Audience-Submitted Cases
11:30 am Lunch
Understanding Newer Roles for Targeted Agents
12:30 pm Targeted Agents: Roles in Transplantation
Jeffrey V. Matous
1:00 pm Clinical Trials to Assess Targeted Agents
Debu Tripathy
1:30 pm Question-and-Answer Session/Panel Discussion With Audience-Submitted Cases
Practical Issues in Cancer Therapy
1:50 pm Cancer Pain Management
Jeannine Brant
2:20 pm Pharmacogenomics: Current Issues in Oncology Therapy
Christine Walko
2:50 pm Postsession Survey and Question-and-Answer Session/Panel Discussion With Audience-Submitted Cases
3:15 pm Adjourn

Educational Grants

An educational grant for this activity was provided by:


  1. Genentech BioOncology
  2. Novartis Oncology